Samantha G.
- Country
- Italy
- Department
- Centro Alzheimer
Research Overview
- Long-term Evaluation of Safety, Tolerability, and Efficacy of AL002 and Florquinitau (18F) in Patients with Alzheimer's Disease
- Efficacy and Safety Evaluation of Mirodenafil Dihydrochloride in Early Alzheimer's Disease: A Phase 3 Double-Blind, Randomized, Placebo-Controlled Trial
- Evaluation of MK-1942 as Adjunctive Therapy in Mild to Moderate Alzheimer's Disease: A Phase 2a/2b Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 22 of 81 partner sites.
Specializations
Neurodegenerative Disorders
The investigator specializes in the study of Alzheimer's Disease, with particular emphasis on therapeutic interventions for various stages of the condition, from early to moderate progression.
- Early-stage Alzheimer's Disease treatment
- Mild to moderate AD dementia management
- Disease progression monitoring
Research activities focus on evaluating novel therapeutic approaches for cognitive decline in AD patients.
Therapeutic Development
Expertise in investigating adjunctive therapy approaches for Alzheimer's Disease, particularly in combination with established treatments like acetylcholinesterase inhibitors.
- Novel therapeutic compounds
- Combination treatment strategies
- Long-term therapeutic safety
The investigator evaluates innovative treatment modalities aimed at improving cognitive function in AD patients.
Clinical Assessment
Specialized in evaluating cognitive function and disease progression through standardized assessment tools such as the ADAS-Cog11 scoring system.
- Cognitive performance measurement
- Safety and tolerability assessment
- Biomarker evaluation
Focus includes comprehensive monitoring of treatment outcomes and safety parameters in AD interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.